skip
net ir
Japanese

Eisai Co., Ltd.

code | 4523Market | TYO1, OSA1Category of Business | Pharmaceutical
Inquiry : 4-6-10, Koishikawa, Bunkyo-ku, Tokyo 112-8088 [Official Homepage]
TEL : 03-3817-3700


Corporate Presentation

2019/05/14
FY2018 (Fiscal Year Ended March 31, 2019) Financial Results Presentation
Representative Corporate Officer and CEO Haruo Naito
300k
2019/04/24
Eisai Scientific Meeting 2019

Presentation material¡¡(PDF:11117KB)
300k
2019/03/11
Information Meeting
Representative Corporate Officer and CEO Haruo Naito
300k
2019/02/05
Q3 FY2018 (Fiscal Year Ending March 31, 2019) Financial Results Presentation
Ryohei Yanagi Chief Financial Officer, Chief IR Officer
GroupIvan Cheung President, Neurology Business
Terushige Iike President, Oncology Business Group
300k




Precautions in use
Nomura IR assumes no responsibility for correctness, validity or any other nature of the contents on this server.
No act such as alteration, modification or addition to the contents is permitted.
Since the contents on this server are not intended to solicit investment, our company has no liability for any trouble related to investment made by any audience based on the contents of this site. Investors are required to decide at their own discretion.
Nomura IR assumes no responsibility for correctness, validity or any other nature of information, including its format and details, obtained from any site linked from our site.

up
Download Plug-in
Get Adobe Reader
Windows Media Player
Real Player
Copyright (c) 2004 Nomura Investor Relations Co., Ltd. All Rights Reserved.
NIR